Am J Physiol Lung Cell Mol Physiol 293: L1385–L1394, 2007. First published September 14, 2007; doi:10.1152/ajplung.00207.2007. Proinflammatory responses of human airway cells to ricin involve stress-activated protein kinases and NF-B John Wong,1 Veselina Korcheva,1 David B. Jacoby,2 and Bruce E. Magun1 1 Department of Cell and Developmental Biology and 2Division of Pulmonary and Critical Care Medicine, Oregon Health and Science University, Portland, Oregon Submitted 22 May 2007; accepted in final form 10 September 2007 in castor beans, the seeds of the castor plant Ricinus communis, which is grown worldwide. From the estimated one million tons of castor beans that are processed every year globally for the production of castor oil and related products, bean mash is produced as waste that contains ⬃5% ricin, which is readily extracted and purified (53). Because of its toxicity, availability, and ease of production, ricin is included in the U.S. Centers for Disease Control and Prevention’s select agent list. Ricin has been studied for development as a bioweapon since the 1940s, was used in an assassination in 1978, and has been possessed by suspected terrorist groups in the U.S. and abroad since the early 1990s, according to numerous news reports. Although most experts believe that ricin would be difficult to use as a weapon of mass destruction, it has the potential to be a weapon of terror in small-scale attacks. We have reported that ricin, when delivered intratracheally by instillation to mice at a lethal dose (20 g/100 g body wt), leads to cellular damage that can be detected in the lungs as well as other organs such as kidney and spleen; at a sublethal dose (2 g/100 g body wt), the damage is restricted primarily to the lungs, although some extrapulmonary tissues display increased levels of expression of proinflammatory transcripts (71). Pulmonary symptoms after ricin delivery by inhalation or instillation into the lungs include pulmonary edema, acute alveolitis, apoptosis, necrosis of the endothelium and epithelium, massive infiltration of inflammatory cells, and hyperplasia of pneumocytes (6, 23, 67, 70, 71). Many proinflammatory genes have binding sites for activator protein-1 (AP-1) and NF-B in their promoter regions, and numerous studies using various inhibitory interventions show the importance of these two classes of regulatory proteins in gene expression (1, 5, 38, 44). The members of the AP-1 family of transcription factors are activated by SAPKs, such as p38 and JNK, which are in turn activated by a cascade of upstream kinases; this cascade is further regulated by phosphatases (recent reviews include Refs. 4, 50, and 67). NF-B is normally sequestered in the cytoplasm, where it is bound to IB; on activation, the IB kinase (IKK) phosphorylates IB, targeting it for proteasome-mediated proteolysis, thereby releasing NF-B to translocate to the nucleus, where it transactivates genes (recent reviews include Refs. 29, 35, and 44). It is generally believed that the primary targets of ricin intoxication are endothelial cells (20) and macrophages (6). Treatment of endothelial cells results in apoptosis (6, 31, 43). Exposure of macrophage cell lines (22, 24, 27, 39) and primary alveolar and marrow-derived macrophages (40) to ricin results in apoptosis, activation of SAPKs, and secretion of chemokines and cytokines. The airway epithelium is the initial barrier that separates inhaled substances such as environmental pollutants, toxins, and infectious organisms from the internal milieu and has become increasingly appreciated for its involvement in host defense. Airway epithelium is able to synthesize and secrete cytoprotective molecules such as mucins and defensins and to signal to cells of the innate and adaptive immune system by expressing adhesion molecules, chemokines, and cytokines (13). Airway epithelial cells are a known source of a large number of chemokines and cytokines (9, 13, 35, 62, 63, 66). As a result, it has become apparent that airway epithelial cells actively participate in inflammatory diseases of the lung such as asthma, chronic obstructive pulmonary disease, acute respi- Address for reprint requests and other correspondence: B. Magun, Oregon Health and Science Univ., 3181 SW Sam Jackson Park Rd., Portland, OR 97239 (e-mail: [email protected]). The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. lung; airway epithelium; inflammation; tumor necrosis factor-␣; p38 mitogen-activated protein kinase; nuclear factor-B RICIN IS A POTENT TOXIN FOUND http://www.ajplung.org 1040-0605/07 $8.00 Copyright © 2007 the American Physiological Society L1385 Downloaded from http://ajplung.physiology.org/ by 10.220.33.6 on June 17, 2017 Wong J, Korcheva V, Jacoby DB, Magun BE. Proinflammatory responses of human airway cells to ricin involve stressactivated protein kinases and NF-B. Am J Physiol Lung Cell Mol Physiol 293: L1385–L1394, 2007. First published September 14, 2007; doi:10.1152/ajplung.00207.2007.—Ricin is a potential bioweapon because of its toxicity, availability, and ease of production. When delivered to the lungs, ricin causes severe pulmonary damage with symptoms that are similar to those observed in acute lung injury and adult respiratory distress syndrome. The airway epithelium plays an important role in the pathogenesis of many lung diseases, but its role in ricin intoxication has not been elucidated. Exposure of cultured primary human airway epithelial cells to ricin resulted in the activation of SAPKs and NF-B and in the increased expression of multiple proinflammatory molecules. Among the genes upregulated by ricin and identified by microarray analysis were those associated with transcription, nucleosome assembly, inflammation, and response to stress. Sequence analysis of the promoters of these genes identified NF-B as one of the transcription factors whose binding sites were overrepresented. Although airway cells secrete TNF-␣ in response to ricin, blocking TNF-␣ did not prevent ricin-induced activation of NF-B. Decreased levels of IB-␣ in airway cells exposed to ricin suggest that translational suppression may be responsible for the activation of NF-B. Inhibition of p38 MAPK by a chemical inhibitor or NF-B by short interfering RNA resulted in a marked reduction in the expression of proinflammatory genes, demonstrating the importance of these two pathways in ricin intoxication. Therefore, the p38 MAPK and NF-B pathways are potential therapeutic targets for reducing the inflammatory consequences of ricin poisoning. L1386 RICIN-INDUCED RESPONSES IN HUMAN AIRWAY CELLS MATERIALS AND METHODS Cells. Primary airway cells were isolated from tracheae (3–5 in) obtained at the Pacific Northwest Transplant Bank from anonymous human organ donors. Tracheae were placed in calcium- and magnesium-containing buffer supplemented with 0.5% pronase, antibiotics, and amphotericin B overnight at 4°C. After incubation, fetal bovine serum was added to a final concentration of 20%, and epithelial cells were detached from the stroma by gentle agitation. The cells were collected by centrifugation at 800 g for 10 min, washed, and suspended in MEM with 5% fetal bovine serum. After overnight cell attachment on collagen-coated plates, the medium was replaced with LHC-9 (Invitrogen, Carlsbad, CA). Experiments with human airway cells were conducted between passages 0 and 4 grown to 70 –90% confluence in LHC-9. Antibodies and other reagents. Antibodies against phospho-JNK (no. 9251), phospho-p38 (no. 4631), and active caspase-3 (no. 9662) were purchased from Cell Signaling Technology (Danvers, MA). Antibodies against p38 (sc-535), the p65 subunit of NF-B (sc-372), and IB-␣ (sc-371) were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Ricin was purchased from Vector Laboratories (Burlingame, CA). SB-203580 (an inhibitor of p38 MAPK) was purchased from Calbiochem (San Diego, CA). Etanercept (Enbrel) was manufactured by Immunex (Thousand Oaks, CA). Immunocytochemistry. Cells were grown on collagen-coated plastic dishes and were fixed with methanol. Cells were then blocked with blocking buffer (PBS ⫹ 1.5% goat serum) and were incubated with primary antibody against p65 subunit of NF-B (sc-372) diluted in blocking buffer overnight. After incubation in biotinylated goat antirabbit secondary antibody, samples were treated with hydrogen peroxide to block endogenous peroxidase and were further processed by using the VECTASTAIN Elite ABC kit (Vector Laboratories, Burlingame, CA) with 3,3⬘-diaminobenzidine as substrate. Incorporation of [3H]leucine. Cells were grown in collagen-coated 24-well culture dishes. Two and one-half hours after the addition of ricin, cells were exposed to 10 Ci of [3H]leucine for 30 min, at which time 10% trichloroacetic acid was added to terminate incorporation. Culture wells were washed three times with 5% trichloroacetic acid, followed by 88% formic acid to solubilize the trichloroacetic acid-insoluble proteins. The samples were counted in a liquid scintillation counter. Measurement of TNF-␣ levels. Cells were cultured in collagencoated 3.5-cm culture dishes and were treated with ricin for 6 h. AJP-Lung Cell Mol Physiol • VOL Medium was collected from each well and was concentrated by ultrafiltration by using Centricon-3 microconcentrators (Millipore, Billerica, MA) to increase sensitivity. Measurement of TNF-␣ in the concentrated samples was performed by using ELISA reagents from eBioscience (San Diego, CA). Immunoblotting. Equal numbers of cells were plated, treated, and lysed in lysis buffer in preparation for immunoblotting. Equal volumes of the cell lysates were separated on a 10% denaturing polyacrylamide gel in the presence of sodium dodecyl sulfate and were transferred onto polyvinylidene difluoride membranes according to standard laboratory procedures. Membranes were incubated with the indicated antibodies and the corresponding horseradish peroxidaseconjugated secondary antibodies; signals were detected by using enhanced chemiluminescence. Quantification of band intensities was performed by scanning of the autoradiograph and analysis by the software IPLab Gel (Signal Analytics, Vienna, VA). Transfection with siRNA. siRNA was transfected into airway cells grown on collagen-coated 2.2-cm wells at 50 nM siRNA per well by using DharmaFECT 4 (Dharmacon, Lafayette, CO) according to the manufacturer’s instructions. A sequence targeting the p65 subunit of NF-B was used singly (74) or in combination with another published sequence targeting the same gene (3). Control siRNA was a published sequence that showed no inhibition of p65 in multiple human cell types (21). We confirmed the inability of this siRNA to reduce expression of p65 in airway epithelial cells. Real-time RT-PCR. Total RNA was harvested from culture dishes by using TRIzol (Invitrogen, Carlsbad, CA), following the manufacturer’s instructions. RNA from each sample was treated with DNase I (Invitrogen) and was reverse transcribed with SuperScript II and oligo(dT) primer (Invitrogen). Real-time RT-PCR was performed by using SYBR Green reagents on an ABI Prism 7900HT (Applied Biosystems, Foster City, CA). Fold induction was calculated for each sample by absolute quantification by using levels of GAPDH for normalization. The nucleotide sequences of the primers used in this study have been previously published (19). Statistical analyses. Each figure panel displays the results of a single experiment that was performed twice with the use of cells from different donors; in all cases, replicate experiments on cells from different donors yielded similar results. Confidence levels of P ⬍ 0.05 were considered statistically significant. Further descriptions of statistical measures for each experiment are included in the figure legends. Microarray analysis. Gene-expression profiling was performed by the Gene Microarray Shared Resource Affymetrix Microarray Core at Oregon Health and Science University. To verify RNA integrity, total RNA was run on 1% agarose gels and was analyzed on an Agilent Bioanalyzer (Palo Alto, CA). Following reverse transcription, each cDNA was hybridized to the HG-U133 Plus 2.0 GeneChip Array (Affymetrix, Santa Clara, CA), which interrogates 47,000 transcripts. Data were processed with Affymetrix GCOS v. 1.2 software (GEO accession no. GSE7845) and were further analyzed by using EASE (http://david.abcc.ncifcrf.gov/ease/ease.jsp) and EXPANDER (http:// www.cs.tau.ac.il/⬃rshamir/expander/expander.html) software. RESULTS TNF-␣ is a cytokine whose increased expression and release have been tied to the generation of inflammatory cascades in multiple tissues and organs (2, 47, 68). To determine whether ricin increases the expression of TNF-␣ mRNA and protein in airway cells, primary cultures of airway cells were exposed to varying concentrations of ricin for 5 or 6 h. TNF-␣ mRNA was measured by real-time RT-PCR, and TNF-␣ content of the culture medium was analyzed by ELISA. Addition of ricin resulted in a dose-dependent increase in mRNA encoding TNF-␣ transcripts (Fig. 1A). 293 • DECEMBER 2007 • www.ajplung.org Downloaded from http://ajplung.physiology.org/ by 10.220.33.6 on June 17, 2017 ratory distress syndrome, and pneumonia (28, 36, 46, 54). However, the direct involvement of the airway epithelium in the pathogenesis of ricin intoxication is unknown. In this study, we demonstrate that exposure of cultured primary human airway epithelial cells to ricin resulted in the activation of SAPKs and NF-B and in the increased expression of multiple proinflammatory molecules. Reduction in the expression of many proinflammatory genes was achieved by blocking the p38 MAPK-mediated pathway with a chemical inhibitor. Similarly, experimental inhibition of NF-B by introduction of short interfering RNA (siRNA) resulted in the inhibition of the expression of proinflammatory genes, demonstrating a previously unknown participation of NF-B in ricin intoxication. Although airway cells secrete TNF-␣ in response to ricin, blocking TNF-␣ did not prevent ricin-induced activation of NF-B. Exposure of cells to ricin resulted in decreased abundance of IB, suggesting that the inhibition of protein synthesis by ricin may lead to turnover of IB and the consequent activation of NF-B. Therefore, ricin may initiate the inflammatory cascade in airway cells by simultaneously activating SAPKs and NF-B. RICIN-INDUCED RESPONSES IN HUMAN AIRWAY CELLS AJP-Lung Cell Mol Physiol • VOL In contrast to the progressive increase in expression of TNF-␣ mRNA that was induced by increasing doses of ricin, the appearance of TNF-␣ protein in the culture increased dramatically at low ricin concentrations but decreased thereafter (Fig. 1B). Ricin doses of 1 ng/ml and 10 ng/ml stimulated a sixfold increase in secreted levels of TNF-␣ protein. Addition of 100 ng/ml ricin to cells resulted in the appearance of slightly less TNF-␣ protein than at 1 or 10 ng/ml ricin. Remarkably, cells exposed to 1,000 ng/ml ricin showed a complete suppression of secreted TNF-␣ protein. We previously reported that exposure of macrophages to increasing doses of ricin resulted in a dose-dependent increase in expression of TNF-␣ mRNA but resulted in a decreased appearance of TNF-␣ in the culture medium at high concentrations of ricin (39). We demonstrated that the inhibition of protein translation at the higher doses of ricin could account for the inability of transcribed TNF-␣ mRNA to be productively translated into protein. To determine whether a similar inhibition of translation could account for the inability of airway cells to secrete TNF-␣ into the culture medium at elevated ricin concentrations, we measured the incorporation of [3H]leucine into these cells between 2.5 and 3 h after the addition of graded doses of ricin (Fig. 1C). The results of this experiment revealed that the incorporation of [3H]leucine decreased to ⬍60% of control values after addition of 1 ng/ml ricin and ⬍3% of control values after addition of 10 ng/ml ricin. Together, the data shown in Fig. 1 demonstrated that primary cultures of human airway cells responded to ricin by progressively increasing the expression of TNF-␣ mRNA. Furthermore, the data suggest that the productive translation and subsequent release of TNF-␣ protein that occur at lower ricin concentrations were progressively impeded at higher concentrations as a consequence of ricin-mediated inhibition of protein synthesis. The ability of ricin to modulate a proinflammatory response has been tied to ricin’s ability to activate the SAPKs in multiple cell types (22, 27, 33, 39). To determine whether ricin activates SAPKs in primary airway cells, we exposed airway cell cultures to ricin and examined the phosphorylation of JNK and p38 MAPK by immunoblotting. Figure 1 demonstrated that exposure of airway cells to concentrations of ricin ⬍100 ng/ml resulted in both the accumulation of TNF-␣ mRNA and its translation into protein. To determine whether ricin would be effective in causing the phosphorylation of SAPKs, we exposed airway cells to concentrations of ricin from 1 to 100 ng/ml. The antibody against phosphorylated JNK detected three bands in Western blotting (Fig. 2A). The two higher-molecular-weight bands represented the phosphorylated forms of p55 and p45 isoforms of JNK. [We employed several methods to determine the identity of the phosphorylated species that appears below p45 JNK, including siRNA knockdown of both JNK species, and have concluded that the band is not a JNK isoform (unpublished data)]. By 2 h after addition, only 100 ng/ml ricin was capable of increasing the phosphorylation of JNK and p38 MAPK (Fig. 2A). By 4 h, ricin induced the phosphorylation of both JNK and p38 MAPK at all concentrations of ricin that were tested. Ricin induces apoptosis in a number of cell types (21, 27, 34, 37, 56). As determined by morphological criteria, ricin at 0.1–10 ng/ml failed to induce apoptosis in airway cells at 6 h (not shown). However, cells exposed to 10 ng/ml became apoptotic at 24 h, as demonstrated by the appearance of the 293 • DECEMBER 2007 • www.ajplung.org Downloaded from http://ajplung.physiology.org/ by 10.220.33.6 on June 17, 2017 Fig. 1. Effect of ricin on protein translation and secretion of TNF-␣ in airway cells. Human airway cells were treated with ricin at indicated doses. A: cells were cultured in 6-cm dishes and were treated with indicated concentrations of ricin for 5 h, at which time cells were processed for RNA isolation and RT-PCR by using specific primers for TNF-␣. Means ⫾ SD of triplicate measurements of each sample are displayed. B: cell cultures in groups of triplicate 3.5-cm dishes were treated with indicated concentrations of ricin for 6 h, at which time medium was collected for determination of TNF-␣ by ELISA. Mean ⫾ SD for each treated group is displayed. C: cells cultured in 24-well dishes were treated with indicated concentrations of ricin for 3 h. Thirty minutes before harvesting, [3H]leucine was added, as described in MATERIALS AND METHODS. Each value represents a mean ⫾ SD of 3H incorporation from triplicate culture wells. Levels of significance are indicated for ricin-treated cells compared with untreated cells: *P ⬍ 0.05; **P ⬍ 0.01; ***P ⬍ 0.001. L1387 L1388 RICIN-INDUCED RESPONSES IN HUMAN AIRWAY CELLS Fig. 2. Effect of ricin on activation of MAPKs in airway cells. Human airway cells in 6-cm dishes were treated with ricin at indicated doses and times. Cell lysates were obtained from each dish and were processed for immunoblotting. Lysates were examined by immunoblotting against antibodies as indicated in each panel. A: cells were treated with serial dilutions of ricin for 2 and 4 h. Reactivity with antibodies against phosphorylated p38 MAPK and phosphorylated JNK are indicated. B: cells were treated with varying concentrations of ricin for 24 h and were reacted with antibodies specific for caspase-3. For both panels, immunoblotting with anti-p38 MAPK served as loading control. p17/p19 cleavage products of caspase-3 (Fig. 2B). In cells exposed to 3 ng/ml, the cleavage of caspase-3 was barely detectable at 24 h, and concentrations of ricin ⬍3 ng/ml failed to induce cleavage of caspase-3 by that time. The appearance of cleavage products of caspase-3 in cells exposed to 10 ng/ml for 24 h was associated with morphological changes characteristic of apoptotic cells (data not shown). The binding of NF-B to the regulatory regions of many proinflammatory genes (52, 61) is critical for the development of proinflammatory responses (5, 44, 65). To determine whether the exposure of airway cells to ricin would lead to the activation of NF-B, cells were treated with ricin and the redistribution of the p65 subunit of NF-B from cytoplasm to nuclei was visualized by immunocytochemical localization of NF-B (Fig. 3). In untreated airway cells, p65 was localized primarily in cytoplasmic regions, with some reaction product apparent in nuclei (Fig. 3A), suggesting that there may be partial activation of NF-B endogenously in some cells. Cells that were exposed to varying concentrations of ricin (1 to 1,000 ng/ml) for varying times (0.5 to 24 h) revealed that the optimal condition for activating NF-B was 100 ng/ml ricin for 6 h (data not shown). Exposure of cells to 100 ng/ml ricin for 6 h resulted in the accumulation of p65 in the nuclei, although considerable p65-specific reactivity remained in the cytoplasm (Fig. 3C). Although ricin has been shown previously to elevate levels of SAPKs in a variety of cells by acting on intracellular transduction pathways (22, 27, 33, 39), the ability of ricin to activate NF-B directly in cell cultures by intracellular mechanisms has not been demonstrated. The activation of NF-B seen in Fig. 3C may have occurred following the ricin-provoked increase in TNF-␣ secretion. To test this possibility, AJP-Lung Cell Mol Physiol • VOL Fig. 3. Effect of etanercept on intranuclear migration of NF-B following exposure of human airway cells to TNF-␣ or ricin. Human airway cells in plastic dishes were treated with 100 ng/ml ricin for 6 h (C and D) or 100 ng/ml TNF-␣ for 0.5 h (E and F) in presence of saline (A, C, and E) or 10 g/ml etanercept (B, D, and F). Cells treated with saline or etanercept looked identical at 0.5 or 6 h, but only those fixed at 6 h were shown (A and B). Cells were fixed and processed for immunocytochemical detection of p65 subunit of NF-B. Size bar (A) represents 20 m for all panels. 293 • DECEMBER 2007 • www.ajplung.org Downloaded from http://ajplung.physiology.org/ by 10.220.33.6 on June 17, 2017 airway cells were exposed to ricin or TNF-␣ in the presence or absence of etanercept (Enbrel), an inhibitor of TNF-␣ activity. Etanercept is a fusion protein that consists of the extracellular ligand-binding portion of the human 75-kDa TNF receptor linked to the Fc portion of IgG1 (48). Addition of TNF-␣ to airway cultures for 30 min led to the nuclear accumulation of NF-B (Fig. 3E), which did not occur in the presence of etanercept (Fig. 3F). However, the nuclear translocation of NF-B in response to ricin was not diminished in the presence of etanercept (Fig. 3D). These data suggest that the nuclear accumulation of NF-B in response to ricin did not result from the ricin-mediated increase in the expression and secretion of TNF-␣. The prominent ricin-mediated activation of SAPKs and the nuclear appearance of NF-B suggest that these signaling pathways participate in the transcriptional activation of genes in airway cells. One nanogram per milliliter ricin was capable RICIN-INDUCED RESPONSES IN HUMAN AIRWAY CELLS AJP-Lung Cell Mol Physiol • VOL Table 1. Selected microarray data from airway cells treated with 1 ng/ml ricin for 24 h Transcription Factors and DNA-Binding Proteins Fold Increase Activating transcription factor 3 Basic leucine zipper nuclear factor 1 CREB binding protein CREB5 Distal-less homeo box 2 Early growth response gene 2 Early growth response gene 3 Early growth response gene 4 E2F transcription factor 7 ETS1 FOSB Histone 1, H4 h1 Histone 1, H2am Histone 1, H4d Histone 1, H3d Histone 1, H3 h Histone 2, H2aa Histone 1, H2bj Histone 1, H2bg Histone 1, H3d Histone 1, H2al Histone 2a, member J Histone 3, H2ae Histone 1, H2ae Histone deacetylase 9 c-Jun L-Myc Microphthalmia-associated transcription factor Nucleear factor, interleukin 3 regulated NF-B, p105 c-Rel Suppressor of cytokine signaling 1 Suppressor of cytokine signaling 4 Suppressor of cyto0kine signaling 3 Regulators of inflammatory response Activator of S phase kinase CCL5 (RANTES) CCL20 CXCL2 (Gro-beta) CXCL3 (Gro-gamma) CXCL-10 (IP-10) CXCL-11 (I-TAC) IL-6 signal transducer, oncostatin M receptor, GP130 Interleukin-1␣ Interleukin 1 receptor-like 1 Interleukin 1 receptor, type II Interleukin 1 family, member 9 Interleukin-6 Interleukin-8 Interleukin-23, alpha subunit (p19) Lymphotoxin beta Receptor-interacting serine-threonine kinase-2 TAK1-binding protein 3 Thrombospondin-1 TRAF-interacting protein TNF-␣ TNF-␣-induced protein 3 TNF-␣-induced protein 8 TNF receptor superfamily, member 19 TNF receptor-associated factor-1 9.8 9.2 3.5 11.3 13.0 39.4 7.5 59.7 3.5 7.5 24.3 17.1 18.3 16.0 21.1 18.4 19.7 10.6 10.6 10.6 14.9 9.8 8.6 8.6 5.7 3.7 13.0 11.3 6.1 5.6 3.5 4.6 4.6 4.3 4.0 6.5 52.0 16.0 12.1 10.6 17.1 3.7 4.6 5.7 3.7 4.3 9.8 8.0 3.7 9.2 3.0 3.0 6.5 3.0 12.1 12.1 4.3 7.5 3.0 sponse-1 (EGR-1), and activating transcription factor 3, which are known to be associated with the transcriptional regulation of proinflammatory genes. Among the proinflammatory transcripts whose expression was increased were the cytokines TNF-␣, IL-1, IL-6, and a number of chemokines. We applied 293 • DECEMBER 2007 • www.ajplung.org Downloaded from http://ajplung.physiology.org/ by 10.220.33.6 on June 17, 2017 of stimulating the phosphorylation of p38 MAPK and JNK by 4 h (Fig. 2A), but the effect of ricin exposure on the levels of TNF-␣ RNA (Fig. 1A) and other proinflammatory transcripts at this time point was small. One nanogram per milliliter ricin failed to induce apoptosis by 24 h (Fig. 2B) and resulted in a dramatic increase in the expression of many proinflammatory transcripts at that time. In previous studies (71), we had determined that maximal increase of proinflammatory transcripts occurred 24 – 48 h following intratracheal instillation of ricin in mice. For these reasons, we determined the expression profile of transcripts in airway cells 24 h after exposure of cells to 1 ng/ml ricin. We employed an unbiased genome-wide analysis of expressed transcripts by using Affymetrix microarrays on HG-U133 Plus 2.0 chips, which interrogate over 47,000 human transcripts (GEO accession no. GSE7845). We then used the GCOS software to compare the signals of our control vs. ricin-treated samples; the statistical-expression algorithm assigned a no-change call if the change P value was ⬍0.0025. Of the set of transcripts analyzed, over 1,660 distinct transcripts were declared upregulated by threefold or greater following administration of ricin. Ninety percent of these upregulated transcripts were found to be significantly different from the control levels based on the change calls. Selected genes from this analysis are listed in Table 1. To identify overrepresented gene-ontology groups and biological pathways associated with the genes upregulated by ricin, two analytical software tools were applied to analyze the microarray data: EASE (30) and EXPANDER (60). EASE automates the process of biological theme determination by analyzing the overrepresentation of genes that belong to categories that are functionally and structurally defined. Table 2 displays the hierarchical analyses of the annotated genes whose expression was induced greater than threefold by 1 ng/ml ricin for 24 h. The most highly overrepresented genes activated following administration of ricin were associated with transcription, nucleosome assembly, inflammation, and response to stress and wounding. The molecular functions of these induced genes were associated with DNA binding, transcriptional regulation, cytokine activity, and chemokine activity; we have previously reported analysis of microarray data by using RNA isolated from the lungs of saline- vs. ricin-treated mice, and similar ontology groups were identified by EASE (71). We further analyzed our microarray data by using the PRIMA module of EXPANDER (17), which identifies transcription factors whose binding sites are enriched in the promoters of input genes. EXPANDER identified 12 transcription factors from airway cells treated with 1 ng/ml ricin for 24 h (Table 3). Also shown in this table are the P values and the frequency (i.e., percentage of identified promoters within the set of input genes). When we reanalyzed our previously published microarray data (71) from lungs of mice treated with 20 g ricin/100 g body wt for 48 h, we identified four transcription factors by using the same software. NF-B is found at or near the top on both lists of transcription factors. Several other transcription factors identified by EXPANDER belong to the forkhead box proteins and paired box proteins, which have been implicated in tissue development and cell proliferation (7, 57). The microarray analyses (GEO accession no. GSE7845) revealed ricin-mediated increased expression of a number of transcription factors such as c-Jun, c-Fos, early growth re- L1389 L1390 RICIN-INDUCED RESPONSES IN HUMAN AIRWAY CELLS Table 2. Overrepresentation analysis of microarray data from airway cells treated with 1 ng/ml ricin for 24 h, as determined by EASE EASE Score Transcription Nucleosome assembly Chromatin assembly Establishment and/or maintenance of chromatin architecture Inflammatory response Innate immune response Response to wounding Response to stress Programmed cell death Molecular Function DNA binding Transcription factor activity Transcription coactivator activity Chemoattractant activity Transcription factor binding Chemokine activity/receptor binding 1.2 ⫻ 10⫺26 2.6 ⫻ 10⫺12 2.1 ⫻ 10⫺9 1.0 ⫻ 10⫺6 1.2 ⫻ 10⫺3 2.1 ⫻ 10⫺3 5.8 ⫻ 10⫺3 8.4 ⫻ 10⫺3 1.6 ⫻ 10⫺2 1.8 ⫻ 10⫺24 9.5 ⫻ 10⫺10 8.8 ⫻ 10⫺3 8.3 ⫻ 10⫺3 1.3 ⫻ 10⫺2 1.9 ⫻ 10⫺2 real-time RT-PCR to the analysis of transcript abundance for several proinflammatory genes and transcription factors to verify their increased expression 24 h after exposure of airway cells to 1 ng/ml ricin. We previously reported that many of these genes, which had been chosen because of their known involvement in the inflammatory process, were upregulated in vivo in the lungs following intratracheal instillation of ricin (71). Figure 4 demonstrates, by real-time RT-PCR, the increased expression of a number of selected chemokines (CXCL1, CCL2, IL-8), cytokines (TNF-␣, IL-1, IL-6), and transcription factors (EGR-1, c-Jun, c-Fos) following exposure of airway cells to ricin. Of the SAPKs, p38 MAPK has been shown to occupy a central role in mediating inflammatory processes (25, 42). To determine the requirement for activated p38 MAPK in ricinmediated expression of proinflammatory transcripts, airway cells were exposed to ricin in the presence of SB-203580, an Table 3. Analysis of transcription factor binding sites as determined by EXPANDER Human airway cells treated with 1 ng/ml ricin for 24 h Transcription Factor P Value Frequency FoxQ1 (HFH-1) NF-B p65 FoxF2 (Freac-2) SRY TATA STAT4 FoxC1 (Freac-3) Tax/CREB FoxD3 HMG-1(Y) Pax-3 FoxO4 3.1 ⫻ 10⫺8 1.8 ⫻ 10⫺6 1.9 ⫻ 10⫺6 7.5 ⫻ 10⫺6 8.1 ⫻ 10⫺6 2.7 ⫻ 10⫺5 3.2 ⫻ 10⫺5 3.3 ⫻ 10⫺5 6.2 ⫻ 10⫺5 6.6 ⫻ 10⫺5 7.4 ⫻ 10⫺5 8.2 ⫻ 10⫺5 18.1 11.8 15.8 31.6 9.7 19.2 15.4 20.0 16.4 20.0 12.0 16.2 Lung from mice treated with 20 g ricin per 100 g body weight Transcription Factor NF-B p65 ISRE Pax-4 NF-B p50 P-Value Frequency 3.4 ⫻ 10 1.3 ⫻ 10⫺5 3.8 ⫻ 10⫺5 8.4 ⫻ 10⫺5 15.2 17.1 28.0 14.7 ⫺12 AJP-Lung Cell Mol Physiol • VOL Fig. 4. Effect of SB-203580 on ricin-mediated increase in expression of proinflammatory RNA transcripts in human airway cells. Cells cultured in 2.2-cm wells were exposed to 1 ng/ml ricin for 24 h in presence (gray bars) or absence (open bars) of 10 M SB-203580. From each well, RNA was extracted and real-time RT-PCR was employed to measure relative abundance of RNA by using primers corresponding to indicated genes, employing GAPDH as an invariant transcript. EGR, early growth response. Values are displayed as means ⫾ SD of triplicate measurements of each sample. Level of significance (***P ⬍ 0.001) is indicated for cells exposed to ricin compared with cells exposed to ricin plus SB-203580. inhibitor that has high specificity for p38 MAPK (8, 41). The efficacy of SB-203580 as an inhibitor of p38 MAPK was verified by using immunoblotting by employing an antibody against phospho-MAPKAP kinase-2 (a specific substrate for p38 MAPK; data not shown). In the presence of SB-203580, the ricin-mediated expression of transcripts that encode a variety of cytokines, chemokines, and transcription factors was reduced significantly (P ⬍ 0.001; Fig. 4), indicating that activation of p38 MAPK was required for ricin-mediated increased expression of these mRNAs. 293 • DECEMBER 2007 • www.ajplung.org Downloaded from http://ajplung.physiology.org/ by 10.220.33.6 on June 17, 2017 Biological Process RICIN-INDUCED RESPONSES IN HUMAN AIRWAY CELLS L1391 Fig. 6. Effect of reduced expression of p65 subunit NF-B on ricin-mediated expression of proinflammatory RNA transcripts in human airway cells. Cells cultured in 2.2-cm wells were transfected with control siRNA (open bars), a single p65 siRNA (gray bars), or a combination of 2 different p65 siRNAs (solid bars). Two days later, cells were treated with saline (control) or with 1 ng/ml ricin for 24 h, at which time RNA was extracted and processed by real-time RT-PCR. Experiment shown was performed contemporaneously with experiment shown in Fig. 5 to verify ability of siRNA to reduce expression of p65 protein. Values are displayed as means ⫾ SD of triplicate measurements of each sample. Levels of significance (*P ⬍ 0.05; **P ⬍ 0.01) are indicated for cells transfected with a single p65 siRNA and exposed to ricin compared with cells transfected with two different p65 siRNAs and exposed to ricin. encode transcription factors whose increased expression has been tied to the activation of cytokines and chemokines. Fig. 5. Effect of reduced expression of p65 subunit NF-B on ricin-mediated activation of MAPKs in human airway cells. Cells in 2.2-cm wells were transfected with control siRNA and 1 or a combination of 2 short interfering RNAs (siRNAs) targeted against p65 subunit of NF-B. Two days later, cells were treated with 1 ng/ml ricin for 24 h, at which time cell lysates were prepared and processed for immunoblotting against antibodies as shown. AJP-Lung Cell Mol Physiol • VOL DISCUSSION Inflammation of airway epithelium caused by bacterial, viral, and fungal pathogens is strongly associated with the activation of pattern-recognition receptors such as the toll-like receptors, Nod1, Nod2, retinoic acid-inducible protein I (RIG- 293 • DECEMBER 2007 • www.ajplung.org Downloaded from http://ajplung.physiology.org/ by 10.220.33.6 on June 17, 2017 Because NF-B is crucially involved in the regulation of a large number of cytokines, chemokines, and other proinflammatory molecules (52, 61), and because we found NF-B binding sites to be enriched in the promoters of genes that were upregulated by ricin (Table 3), we determined whether NF-B was required for airway cells to respond to ricin. To this end, we applied siRNA-mediated knockdown of the p65 subunit (RelA) of NF-B before exposure of airway cells to ricin. Following exposure of cells to one p65 siRNA or a combination of two different p65 siRNAs, levels of p65 NF-B protein were reduced by ⬃70% when compared with exposure to control siRNA alone (Fig. 5). Knockdown of p65 NF-B did not interfere with the levels of JNK and p38 MAPK (data not shown) nor the ability of 1 ng/ml ricin to induce the phosphorylation of these two SAPKs, demonstrating the absence of nonspecific effects on these kinases. Interestingly, cells exposed to ricin exhibited diminished levels of IB-␣ (lanes 2, 4, and 6), a molecule that is responsible for inhibiting NF-B activation by preventing its nuclear translocation (29, 35, 44). To determine whether p65 NF-B was required for the ricin-mediated expression of proinflammatory mRNAs, we exposed control or NF-B-deficient airway cells to 1 ng/ml ricin and determined the expression of transcripts 24 h later (Fig. 6). Reduction of NF-B abundance resulted in the reduced expression of TNF-␣, IL-1, CXCL1, CCL2, and IL-8 (P ⬍ 0.01) but not IL-6 or the transcription factors EGR-1, c-Jun, and c-Fos. A slightly larger decrease in expression was observed when two p65 siRNAs were used in combination for TNF-␣, IL-1, CXCL1, and CCL2, with P values as shown. Together, Figs. 4, 5, and 6 demonstrate that the ricin-mediated expression of a variety of mRNA molecules associated with inflammation requires the activation of p38 MAPK and that a subset of these transcripts also requires the activation of NFB. Some transcripts that are independent of NF-B activation L1392 RICIN-INDUCED RESPONSES IN HUMAN AIRWAY CELLS AJP-Lung Cell Mol Physiol • VOL intoxication produces responses that are similar to those observed in chronic obstructive pulmonary disease, acute lung injury, and adult respiratory distress syndrome. One of the genes that has been studied extensively in lung inflammation and injury encodes the antimicrobial chemokine CCL20/macrophage inflammatory protein (MIP)-3␣, which is secreted by airway cells and has chemical properties both as a chemoattractant and as a -defensin (64, 73). Expression of CCL20/ MIP-3␣ was increased by ricin (Table 1). In addition to proinflammatory genes, ricin increased the expression of many histones (Table 1), a response that also occurs in keratinocytes following UV irradiation (10). Elevation of histone expression has been employed as a marker for cell proliferation (26) and may be a general response to toxic stimuli. TNF-␣ has been shown to play a major role in many inflammatory diseases of the lung (reviewed in Ref. 47). In addition to stimulating its own transcription in different cell types (49, 51), TNF-␣ upregulates the expression of many other proinflammatory transcripts (15) and causes the release of CCL5 and soluble ICAM-1 from airway cells (69). Because TNF-␣ directly activates both p38 MAPK and NF-B (12, 32), it is reasonable to speculate that TNF-␣ may be responsible for the activation of NF-B by ricin by an autocrine mechanism. However, blocking the TNF-␣ pathway by use of etanercept was unable to prevent the nuclear translocation of NF-B induced by ricin (Fig. 3), suggesting that ricin may activate NF-B via another secreted molecule or may directly activate the NF-B pathway in the absence of autocrine signaling by an unknown mechanism. Translational repression induced by UV radiation or double-stranded RNA results in the inhibition of new synthesis of IB and in the consequent activation of NF-B (11, 72). Our data demonstrating substantial reduction in the level of IB-␣ protein following administration of ricin to airway cells (Fig. 5) supports the notion that the direct effect of ricin on inhibition of protein synthesis may be responsible for activation of NF-B. ACKNOWLEDGMENTS We acknowledge excellent technical assistance of David E. Purdy and Thanh-Hoai Dinh and thank the members of the Pacific Northwest Transplant Bank for their help in obtaining human tracheas. The Institutional Review Board at Oregon Health and Science University granted an exemption for this research. GRANTS These studies were supported by grants ES-889456 and AI-1059335, HL-71795, HL-54659, and HL61013 from the National Institutes of Health. REFERENCES 1. Adcock IM. Transcription factors as activators of gene transcription: AP-1 and NF-kappa B. Monaldi Arch Chest Dis 52: 178 –186, 1997. 2. Aggarwal BB, Natarajan K. Tumor necrosis factors: developments during the last decade. Eur Cytokine Netw 7: 93–124, 1996. 3. Anderson LA, Perkins ND. Regulation of RelA (p65) function by the large subunit of replication factor C. Mol Cell Biol 23: 721–732, 2003. 4. Ashwell JD. The many paths to p38 mitogen-activated protein kinase activation in the immune system. Nat Rev Immunol 6: 532–540, 2006. 5. Baeuerle PA, Henkel T. Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 12: 141–179, 1994. 6. Brown RF, White DE. Ultrastructure of rat lung following inhalation of ricin aerosol. Int J Exp Pathol 78: 267–276, 1997. 7. Carlsson P, Mahlapuu M. Forkhead transcription factors: key players in development and metabolism. Dev Biol 250: 1–23, 2002. 293 • DECEMBER 2007 • www.ajplung.org Downloaded from http://ajplung.physiology.org/ by 10.220.33.6 on June 17, 2017 I), and others (28, 59). The transcription of proinflammatory genes associated with these signaling pathways is dependent on the activation of SAPKs and NF-B (16, 28). Chemical inhibitors such as SB-203580 have been frequently used to study the requirement for activation of p38 MAPK in many inflammatory models, including lung inflammation following cardiopulmonary bypass (14), cystic fibrosis (55), and ovalbumin-induced allergy in the airway (18). The role of NF-B in airway inflammation was confirmed by the demonstration that the adenoviral vector-mediated overexpression of IKK in airway epithelial cells of mice was sufficient for NF-B activation, production of inflammatory mediators, and recruitment of neutrophils to the lungs (58). In contrast to pathogen-associated inflammatory processes, far less is known about the sensory and transduction machinery that is activated on exposure of the lungs to toxins and other noxious xenobiotics. Although the precise mechanisms by which the pulmonary system responds to environmental agents have not been elucidated, it has been suggested that airway cells are likely to play a fundamental role (46). Elucidation of the transduction pathways involved in responding to xenobiotics is complicated by an incomplete understanding of the receptors and signaling intermediates that lead, ultimately, to the elaboration of proinflammatory mediators. Unlike most other xenobiotic agents, the binding and intracellular actions of ricin have been well studied (33, 45). The depurination of a single nucleotide in 28S RNA (A4324) by ricin leads to the activation of kinases that are situated upstream of the SAPKs, JNK, and p38 MAPK (33). Only translation inhibitors that bind to, or produce structural alterations within, the peptidyl transferase center of 28S rRNA were capable of activating the SAPKs. Translation inhibitors that act through other mechanisms such as ribosomal translocation (e.g., cycloheximide, emetine, and diphtheria toxin) failed to activate the SAPKs (33), demonstrating that the inhibition of translation per se is not sufficient to account for the activation of the SAPKs. Because perturbation of the peptidyl transferase center by a variety of agents leads to the rapid activation of the SAPKs (i.e., ⬍3 min), we proposed that this unique signaling device was coupled to the activation of upstream kinases through a novel mechanism (33). Our studies demonstrate that both p38 MAPK and NF-B play important roles in the response of human airway cells to ricin, as shown by the ability of either SB-203580 or siRNA against p65 NF-B to suppress the ricin-mediated increase in proinflammatory transcripts (Figs. 4 and 6). Additional MAPK pathways such as JNK and ERK may also be involved in ricin-mediated proinflammatory responses, although these pathways were not a focus of our studies. Our microarray analysis provided an extensive list of genes whose expression was elevated in airway cells following treatment with ricin. Many of these genes encode proinflammatory chemokines and cytokines (Tables 1 and 2), further strengthening the hypothesis that airway cells play an important role in lung inflammation. We (71) previously instilled ricin into the lungs of mice and observed activation of SAPKs and NF-B as well as increased expression of proinflammatory genes, including cytokines, chemokines, adhesion molecules, repair and remodeling enzymes, and transcription factors. The activation of these signaling pathways and profile of upregulated genes, both in vivo and in vitro, demonstrate that ricin-mediated RICIN-INDUCED RESPONSES IN HUMAN AIRWAY CELLS AJP-Lung Cell Mol Physiol • VOL 31. Hughes JN, Lindsay CD, Griffiths GD. Morphology of ricin and abrin exposed endothelial cells is consistent with apoptotic cell death. Hum Exp Toxicol 15: 443– 451, 1996. 32. Ichijo H. From receptors to stress-activated MAP kinases. Oncogene 18: 6087– 6093, 1999. 33. Iordanov MS, Pribnow D, Magun JL, Dinh TH, Pearson JA, Chen SL, Magun BE. Ribotoxic stress response: activation of the stress-activated protein kinase JNK1 by inhibitors of the peptidyl transferase reaction and by sequence-specific RNA damage to the alpha-sarcin/ricin loop in the 28S rRNA. Mol Cell Biol 17: 3373–3381, 1997. 34. Kageyama A, Kusano I, Tamura T, Oda T, Muramatsu T. Comparison of the apoptosis-inducing abilities of various protein synthesis inhibitors in U937 cells. Biosci Biotechnol Biochem 66: 835– 839, 2002. 35. Karin M. Nuclear factor-kappaB in cancer development and progression. Nature 441: 431– 436, 2006. 36. Kato A, Truong-Tran AQ, Scott AL, Matsumoto K, Schleimer RP. Airway epithelial cells produce B cell-activating factor of TNF family by an IFN-beta-dependent Mechanism. J Immunol 177: 7164 –7172, 2006. 37. Khan T, Waring P. Macrophage adherence prevents apoptosis induced by ricin. Eur J Cell Biol 62: 406 – 414, 1993. 38. Koj A. Initiation of acute phase response and synthesis of cytokines. Biochim Biophys Acta 1317: 84 –94, 1996. 39. Korcheva V, Wong J, Corless C, Iordanov M, Magun B. Administration of ricin induces a severe inflammatory response via nonredundant stimulation of ERK, JNK, and p38 MAPK and provides a mouse model of hemolytic uremic syndrome. Am J Pathol 166: 323–339, 2005. 40. Korcheva V, Wong J, Lindauer M, Jacoby DB, Iordanov MS, Magun B. Role of apoptotic signaling pathways in regulation of inflammatory responses to ricin in primary murine macrophages. Mol Immunol 44: 2761–2771, 2007. 41. Lee JC, Kassis S, Kumar S, Badger A, Adams JL. p38 mitogenactivated protein kinase inhibitors—mechanisms and therapeutic potentials. Pharmacol Ther 82: 389 –397, 1999. 42. Lee JC, Kumar S, Griswold DE, Underwood DC, Votta BJ, Adams JL. Inhibition of p38 MAP kinase as a therapeutic strategy. Immunopharmacology 47: 185–201, 2000. 43. Lindstrom AL, Erlandsen SL, Kersey JH, Pennell CA. An in vitro model for toxin-mediated vascular leak syndrome: ricin toxin A chain increases the permeability of human endothelial cell monolayers. Blood 90: 2323–2334, 1997. 44. Liu SF, Malik AB. NF-kappa B activation as a pathological mechanism of septic shock and inflammation. Am J Physiol Lung Cell Mol Physiol 290: L622–L645, 2006. 45. Lord MJ, Jolliffe NA, Marsden CJ, Pateman CS, Smith DC, Spooner RA, Watson PD, Roberts Ricin LM. Mechanisms of cytotoxicity. Toxicol Rev 22: 53– 64, 2003. 46. Mills PR, Davies RJ, Devalia JL. Airway epithelial cells, cytokines, and pollutants. Am J Respir Crit Care Med 160: S38 –S43, 1999. 47. Mukhopadhyay S, Hoidal JR, Mukherjee TK. Role of TNFalpha in pulmonary pathophysiology. Respir Res 7: 125, 2006. 48. Murray KM, Dahl SL. Recombinant human tumor necrosis factor receptor (p75) Fc fusion protein (TNFR:Fc) in rheumatoid arthritis. Ann Pharmacother 31: 1335–1338, 1997. 49. Nilsen EM, Johansen FE, Jahnsen FL, Lundin KE, Scholz T, Brandtzaeg P, Haraldsen G. Cytokine profiles of cultured microvascular endothelial cells from the human intestine. Gut 42: 635– 642, 1998. 50. Nishina H, Nakagawa K, Azuma N, Katada T. Activation mechanism and physiological roles of stress-activated protein kinase/c-Jun NH2terminal kinase in mammalian cells. J Biol Regul Homeost Agents 17: 295–302, 2003. 51. Onishi H, Kuroki H, Matsumoto K, Baba E, Sasaki N, Kuga H, Tanaka M, Katano M, Morisaki T. Monocyte-derived dendritic cells that capture dead tumor cells secrete IL-12 and TNF-alpha through IL-12/TNF-alpha/NF-kappaB autocrine loop. Cancer Immunol Immunother 53: 1093–1100, 2004. 52. Pahl HL. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18: 6853– 6866, 1999. 53. Patocka J, Streda L. Protein biotoxins of military significance. Acta Medica (Hradec Kralove) 49: 3–11, 2006. 54. Polito AJ, Proud D. Epithelia cells as regulators of airway inflammation. J Allergy Clin Immunol 102: 714 –718, 1998. 55. Raia V, Maiuri L, Ciacci C, Ricciardelli I, Vacca L, Auricchio S, Cimmino M, Cavaliere M, Nardone M, Cesaro A, Malcolm J, Qua- 293 • DECEMBER 2007 • www.ajplung.org Downloaded from http://ajplung.physiology.org/ by 10.220.33.6 on June 17, 2017 8. Cuenda A, Rouse J, Doza YN, Meier R, Cohen P, Gallagher TF, Young PR, Lee JC. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett 364: 229 –233, 1995. 9. Davies DE. The bronchial epithelium: translating gene and environment interactions in asthma. Curr Opin Allergy Clin Immunol 1: 67–71, 2001. 10. Dazard JE, Gal H, Amariglio N, Rechavi G, Domany E, Givol D. Genome-wide comparison of human keratinocyte and squamous cell carcinoma responses to UVB irradiation: implications for skin and epithelial cancer. Oncogene 22: 2993–3006, 2003. 11. Deng J, Lu PD, Zhang Y, Scheuner D, Kaufman RJ, Sonenberg N, Harding HP, Ron D. Translational repression mediates activation of nuclear factor kappa B by phosphorylated translation initiation factor 2. Mol Cell Biol 24: 10161–10168, 2004. 12. Devin A, Cook A, Lin Y, Rodriguez Y, Kelliher M, Liu Z. The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1: TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation. Immunity 12: 419 – 429, 2000. 13. Diamond G, Legarda D, Ryan LK. The innate immune response of the respiratory epithelium. Immunol Rev 173: 27–38, 2000. 14. Dong X, Liu Y, Du M, Wang Q, Yu CT, Fan X. p38 mitogen-activated protein kinase inhibition attenuates pulmonary inflammatory response in a rat cardiopulmonary bypass model. Eur J Cardiothorac Surg 30: 77– 84, 2006. 15. dos Santos CC, Han B, Andrade CF, Bai X, Uhlig S, Hubmayr R, Tsang M, Lodyga M, Keshavjee S, Slutsky AS, Liu M. DNA microarray analysis of gene expression in alveolar epithelial cells in response to TNFalpha, LPS, and cyclic stretch. Physiol Genomics 19: 331–342, 2004. 16. Dunne A, O’Neill LA. The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense. Sci STKE 2003: re3, 2003. 17. Elkon R, Linhart C, Sharan R, Shamir R, Shiloh Y. Genome-wide in silico identification of transcriptional regulators controlling the cell cycle in human cells. Genome Res 13: 773–780, 2003. 18. Escott KJ, Belvisi MG, Birrell MA, Webber SE, Foster ML, Sargent CA. Effect of the p38 kinase inhibitor, SB 203580, on allergic airway inflammation in the rat. Br J Pharmacol 131: 173–176, 2000. 19. Farley SM, Dotson AD, Purdy DE, Sundholm AJ, Schneider P, Magun BE, Iordanov MS. Fas ligand elicits a caspase-independent proinflammatory response in human keratinocytes: implications for dermatitis. J Invest Dermatol 126: 2438 –2451, 2006. 20. Fu XJ, Iijima K, Nozu K, Hamahira K, Tanaka R, Oda T, Yoshikawa N, Matsuo M. Role of p38 MAP kinase pathway in a toxin-induced model of hemolytic uremic syndrome. Pediatr Nephrol 19: 844 – 852, 2004. 21. Gan YH, Peng SQ, Liu HY. Molecular mechanism of apoptosis induced by ricin in HeLa cells. Acta Pharmacol Sin 21: 243–248, 2000. 22. Gonzalez TV, Farrant SA, Mantis NJ. Ricin induces IL-8 secretion from human monocyte/macrophages by activating the p38 MAP kinase pathway. Mol Immunol 43: 1920 –1923, 2006. 23. Griffiths GD, Rice P, Allenby AC, Bailey SC, Upshall DG. Inhalation toxicology and histopathology of ricin and abrin toxins. Inhal Toxicol 7: 269 –288, 1995. 24. Hassoun E, Wang X. Ricin-induced toxicity in the macrophage J744A.1 cells: the role of TNF-alpha and the modulation effects of TNF-alpha polyclonal antibody. J Biochem Mol Toxicol 14: 95–101, 2000. 25. Herlaar E, Brown Z. p38 MAPK signalling cascades in inflammatory disease. Mol Med Today 5: 439 – 447, 1999. 26. Hewitson TD, Kelynack KJ, Darby IA. Histochemical localization of cell proliferation using in situ hybridization for histone mRNA. Methods Mol Biol 326: 219 –226, 2006. 27. Higuchi S, Tamura T, Oda T. Cross-talk between the pathways leading to the induction of apoptosis and the secretion of tumor necrosis factoralpha in ricin-treated RAW 264.7 cells. J Biochem (Tokyo) 134: 927–933, 2003. 28. Hippenstiel S, Opitz B, Schmeck B, Suttorp N. Lung epithelium as a sentinel and effector system in pneumonia—molecular mechanisms of pathogen recognition and signal transduction. Respir Res 7: 97, 2006. 29. Hoffmann A, Natoli G, Ghosh G. Transcriptional regulation via the NF-kappaB signaling module. Oncogene 25: 6706 – 6716, 2006. 30. Hosack DA, Dennis G Jr, Sherman BT, Lane HC, Lempicki RA. Identifying biological themes within lists of genes with EASE. Genome Biol 4: R70, 2003. L1393 L1394 56. 57. 58. 59. 60. 62. 63. 64. ratino S, Londei M. Inhibition of p38 mitogen activated protein kinase controls airway inflammation in cystic fibrosis. Thorax 60: 773–780, 2005. Rao PV, Jayaraj R, Bhaskar AS, Kumar O, Bhattacharya R, Saxena P, Dash PK, Vijayaraghavan R. Mechanism of ricin-induced apoptosis in human cervical cancer cells. Biochem Pharmacol 69: 855– 865, 2005. Robson EJ, He SJ, Eccles MR. A PANorama of PAX genes in cancer and development. Nat Rev Cancer 6: 52– 62, 2006. Sadikot RT, Han W, Everhart MB, Zoia O, Peebles RS, Jansen ED, Yull FE, Christman JW, Blackwell TS. Selective I kappa B kinase expression in airway epithelium generates neutrophilic lung inflammation. J Immunol 170: 1091–1098, 2003. Sha Q, Truong-Tran AQ, Plitt JR, Beck LA, Schleimer RP. Activation of airway epithelial cells by toll-like receptor agonists. Am J Respir Cell Mol Biol 31: 358 –364, 2004. Shamir R, Maron-Katz A, Tanay A, Linhart C, Steinfeld I, Sharan R, Shiloh Y, Elkon R. EXPANDER–an integrative program suite for microarray data analysis. BMC Bioinformatics 6: 232, 2005. Siebenlist U, Franzoso G, Brown K. Structure, regulation and function of NF-kappa B. Annu Rev Cell Biol 10: 405– 455, 1994. Simon RH, Paine R 3rd. Participation of pulmonary alveolar epithelial cells in lung inflammation. J Lab Clin Med 126: 108 –118, 1995. Smit JJ, Lukacs NW. A closer look at chemokines and their role in asthmatic responses. Eur J Pharmacol 533: 277–288, 2006. Starner TD, Barker CK, Jia HP, Kang Y, McCray PB Jr. CCL20 is an inducible product of human airway epithelia with innate immune properties. Am J Respir Cell Mol Biol 29: 627– 633, 2003. AJP-Lung Cell Mol Physiol • VOL 65. Tak PP, Firestein GS. NF-kappaB: a key role in inflammatory diseases. J Clin Invest 107: 7–11, 2001. 66. Takizawa H. Cytokines/chemokines and adhesion molecules in local inflammatory responses of the lung. Drug News Perspect 11: 611– 619, 1998. 67. Tamura S, Hanada M, Ohnishi M, Katsura K, Sasaki M, Kobayashi T. Regulation of stress-activated protein kinase signaling pathways by protein phosphatases. Eur J Biochem 269: 1060 –1066, 2002. 68. Tracey KJ, Cerami A. Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu Rev Med 45: 491–503, 1994. 69. Wang JH, Devalia JL, Sapsford RJ, Davies RJ. Effect of corticosteroids on release of RANTES and sICAM-1 from cultured human bronchial epithelial cells, induced by TNF-alpha. Eur Respir J 10: 834 – 840, 1997. 70. Wilhelmsen CL, Pitt ML. Lesions of acute inhaled lethal ricin intoxication in rhesus monkeys. Vet Pathol 33: 296 –302, 1996. 71. Wong J, Korcheva V, Jacoby DB, Magun B. Intrapulmonary delivery of ricin at high dosage triggers a systemic inflammatory response and glomerular damage. Am J Pathol 170: 1497–1510, 2007. 72. Wu S, Tan M, Hu Y, Wang JL, Scheuner D, Kaufman RJ. Ultraviolet light activates NFkappaB through translational inhibition of IkappaBalpha synthesis. J Biol Chem 279: 34898 –34902, 2004. 73. Yang D, Chen Q, Hoover DM, Staley P, Tucker KD, Lubkowski J, Oppenheim JJ. Many chemokines including CCL20/MIP-3alpha display antimicrobial activity. J Leukoc Biol 74: 448 – 455, 2003. 74. Zhou A, Scoggin S, Gaynor RB, Williams NS. Identification of NFkappa B-regulated genes induced by TNFalpha utilizing expression profiling and RNA interference. Oncogene 22: 2054 –2064, 2003. 293 • DECEMBER 2007 • www.ajplung.org Downloaded from http://ajplung.physiology.org/ by 10.220.33.6 on June 17, 2017 61. RICIN-INDUCED RESPONSES IN HUMAN AIRWAY CELLS
© Copyright 2026 Paperzz